Logo image of CS.PA

AXA SA (CS.PA) Stock Fundamental Analysis

EPA:CS - Euronext Paris - Matif - FR0000120628 - Common Stock - Currency: EUR

40.23  -0.1 (-0.25%)

Fundamental Rating

5

CS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 34 industry peers in the Insurance industry. CS has only an average score on both its financial health and profitability. CS has a correct valuation and a medium growth rate. CS also has an excellent dividend rating. These ratings could make CS a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CS had positive earnings in the past year.
In the past year CS had a positive cash flow from operations.
CS had positive earnings in each of the past 5 years.
In the past 5 years CS always reported a positive cash flow from operatings.
CS.PA Yearly Net Income VS EBIT VS OCF VS FCFCS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

CS has a Return On Assets of 1.18%. This is in the better half of the industry: CS outperforms 61.76% of its industry peers.
The Return On Equity of CS (15.39%) is better than 61.76% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.33%, CS is in the better half of the industry, outperforming 61.76% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CS is in line with the industry average of 2.22%.
The last Return On Invested Capital (1.33%) for CS is above the 3 year average (1.29%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.18%
ROE 15.39%
ROIC 1.33%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
CS.PA Yearly ROA, ROE, ROICCS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CS has a Profit Margin of 8.80%. This is comparable to the rest of the industry: CS outperforms 44.12% of its industry peers.
In the last couple of years the Profit Margin of CS has grown nicely.
The Operating Margin of CS (12.32%) is comparable to the rest of the industry.
CS's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.32%
PM (TTM) 8.8%
GM N/A
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
CS.PA Yearly Profit, Operating, Gross MarginsCS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CS is destroying value.
The number of shares outstanding for CS has been reduced compared to 1 year ago.
Compared to 5 years ago, CS has less shares outstanding
Compared to 1 year ago, CS has a worse debt to assets ratio.
CS.PA Yearly Shares OutstandingCS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CS.PA Yearly Total Debt VS Total AssetsCS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B

2.2 Solvency

CS has an Altman-Z score of 0.35. This is a bad value and indicates that CS is not financially healthy and even has some risk of bankruptcy.
CS has a better Altman-Z score (0.35) than 88.24% of its industry peers.
The Debt to FCF ratio of CS is 2.19, which is a good value as it means it would take CS, 2.19 years of fcf income to pay off all of its debts.
CS's Debt to FCF ratio of 2.19 is fine compared to the rest of the industry. CS outperforms 70.59% of its industry peers.
A Debt/Equity ratio of 0.53 indicates that CS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.53, CS is in the better half of the industry, outperforming 64.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 2.19
Altman-Z 0.35
ROIC/WACC0.12
WACC10.64%
CS.PA Yearly LT Debt VS Equity VS FCFCS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

CS has a Current Ratio of 0.87. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
CS's Current ratio of 0.87 is amongst the best of the industry. CS outperforms 82.35% of its industry peers.
A Quick Ratio of 0.87 indicates that CS may have some problems paying its short term obligations.
CS's Quick ratio of 0.87 is amongst the best of the industry. CS outperforms 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.87
CS.PA Yearly Current Assets VS Current LiabilitesCS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.08% over the past year.
CS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.09% yearly.
The Revenue has been growing slightly by 4.38% in the past year.
The Revenue has been decreasing by -8.16% on average over the past years.
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%

3.2 Future

The Earnings Per Share is expected to grow by 6.32% on average over the next years.
Based on estimates for the next years, CS will show a quite strong growth in Revenue. The Revenue will grow by 8.94% on average per year.
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y6.32%
Revenue Next Year5.42%
Revenue Next 2Y5.1%
Revenue Next 3Y4.18%
Revenue Next 5Y8.94%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CS.PA Yearly Revenue VS EstimatesCS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B 80B 100B
CS.PA Yearly EPS VS EstimatesCS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.21 indicates a reasonable valuation of CS.
Based on the Price/Earnings ratio, CS is valued a bit cheaper than 67.65% of the companies in the same industry.
When comparing the Price/Earnings ratio of CS to the average of the S&P500 Index (28.92), we can say CS is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 10.04, the valuation of CS can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CS indicates a somewhat cheap valuation: CS is cheaper than 61.76% of the companies listed in the same industry.
CS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.65.
Industry RankSector Rank
PE 11.21
Fwd PE 10.04
CS.PA Price Earnings VS Forward Price EarningsCS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CS indicates a somewhat cheap valuation: CS is cheaper than 61.76% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.43
EV/EBITDA N/A
CS.PA Per share dataCS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.97
PEG (5Y)0.62
EPS Next 2Y9.13%
EPS Next 3Y8.44%

7

5. Dividend

5.1 Amount

CS has a Yearly Dividend Yield of 5.44%, which is a nice return.
CS's Dividend Yield is a higher than the industry average which is at 4.79.
Compared to an average S&P500 Dividend Yield of 2.51, CS pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.44%

5.2 History

On average, the dividend of CS grows each year by 8.12%, which is quite nice.
Dividend Growth(5Y)8.12%
Div Incr Years3
Div Non Decr Years3
CS.PA Yearly Dividends per shareCS.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

CS pays out 57.97% of its income as dividend. This is a bit on the high side, but may be sustainable.
CS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP57.97%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
CS.PA Yearly Income VS Free CF VS DividendCS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
CS.PA Dividend Payout.CS.PA Dividend Payout, showing the Payout Ratio.CS.PA Dividend Payout.PayoutRetained Earnings

AXA SA

EPA:CS (4/24/2025, 7:00:00 PM)

40.23

-0.1 (-0.25%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)03-19 2025-03-19/bmo
Earnings (Next)08-01 2025-08-01
Inst Owners36.79%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap89.11B
Analysts80
Price Target42.82 (6.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.44%
Yearly Dividend2.02
Dividend Growth(5Y)8.12%
DP57.97%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.69%
PT rev (3m)6.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.58%
EPS NY rev (3m)-1.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.21%
Valuation
Industry RankSector Rank
PE 11.21
Fwd PE 10.04
P/S 1.02
P/FCF 7.43
P/OCF 7.15
P/B 1.78
P/tB 3.25
EV/EBITDA N/A
EPS(TTM)3.59
EY8.92%
EPS(NY)4.01
Fwd EY9.96%
FCF(TTM)5.41
FCFY13.46%
OCF(TTM)5.63
OCFY13.99%
SpS39.43
BVpS22.55
TBVpS12.36
PEG (NY)0.97
PEG (5Y)0.62
Profitability
Industry RankSector Rank
ROA 1.18%
ROE 15.39%
ROCE 1.67%
ROIC 1.33%
ROICexc 1.37%
ROICexgc 1.79%
OM 12.32%
PM (TTM) 8.8%
GM N/A
FCFM 13.73%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
ROICexc(3y)1.34%
ROICexc(5y)1.16%
ROICexgc(3y)1.75%
ROICexgc(5y)1.48%
ROCE(3y)1.62%
ROCE(5y)1.41%
ROICexcg growth 3Y10.47%
ROICexcg growth 5Y16.55%
ROICexc growth 3Y8.69%
ROICexc growth 5Y14.36%
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 2.19
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.54%
Interest Coverage 1.72
Cash Conversion N/A
Profit Quality 156.03%
Current Ratio 0.87
Quick Ratio 0.87
Altman-Z 0.35
F-Score7
WACC10.64%
ROIC/WACC0.12
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.4%
Profit Quality(3y)104.89%
Profit Quality(5y)238.88%
High Growth Momentum
Growth
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y6.32%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%
Revenue Next Year5.42%
Revenue Next 2Y5.1%
Revenue Next 3Y4.18%
Revenue Next 5Y8.94%
EBIT growth 1Y18.59%
EBIT growth 3Y2.9%
EBIT growth 5Y10.41%
EBIT Next Year25.76%
EBIT Next 3Y11.02%
EBIT Next 5YN/A
FCF growth 1Y240.94%
FCF growth 3Y7.74%
FCF growth 5Y9.94%
OCF growth 1Y216.74%
OCF growth 3Y7.85%
OCF growth 5Y9.48%